Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

Presentation TCT 2024

TCT 1012: Pre-Emptive PCI in Vulnerable Coronary Plaques Reduces Biomechanical and Anatomic High-Risk Features: The PROSPECT ABSORB Trial

Presenter: Diaa Hakim

October 29, 2024

Presentation TCT 2024

TCT 1017: First-in-Human Intracoronary Structural-Molecular Imaging for Multi-Targeted Characterization of High-Risk Plaques in Patients With Coronary Artery Disease

Presenter: Dong Oh Kang

October 29, 2024

Presentation TCT 2024

Con

Presenter: Gary Mintz

October 28, 2024

Presentation TCT 2024

Pro

Presenter: Duk-Woo Park

October 28, 2024

Presentation TCT 2024

TCT 1010: Enhanced Clinical Benefit of Preventive PCI of Vulnerable Coronary Plaques in Patients With Concomitant Non-Target Vessel PCI: A Prespecified Subgroup Analysis of the PREVENT Trial

Presenter: Soo Yeon An

October 28, 2024

Presentation TCT 2024

Lipid Burden and Efficacy of Preventive PCI in Vulnerable Atherosclerotic Coronary Plaques: Post-hoc Analysis of PREVENT Trial

Presenter: Jung-Min Ahn

October 27, 2024

Presentation TCT 2023

Are Progression/Regression Studies “Good Enough” Surrogates for Rcts With Clinical Endpoints?

Presenter: David Erlinge

October 24, 2023

Presentation TCT 2023

Vulnerable Plaque Stabilization: Lessons From Serial Intravascular Imaging Studies

Presenter: Takashi Kubo

October 24, 2023

Presentation TCT 2023

Vulnerable Plaque Detection: The Time Has Passed

Presenter: Daniele Giacoppo

October 24, 2023

Presentation TCT 2023

Vulnerable Plaque Detection: We Must Keep Looking

Presenter: Bjorn Redfors

October 24, 2023

Presentation TCT 2023

What Is a Vulnerable Plaque? Lessons From Intravascular Imaging

Presenter: Gary Mintz

October 24, 2023

Presentation TCT 2023

What Is a Vulnerable Plaque? Lessons From Histopathology

Presenter: Aloke Finn

October 24, 2023

Presentation TCT 2023

Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: The DEBuT-LRP Study

Presenter: Bimmer Claessen

October 24, 2023

Presentation TCT 2020

The PROSPECT ABSORB Trial: Randomized Evaluation of Vulnerable Plaque Treatment with Percutaneous Coronary Intervention

Presenter: Gregg Stone

October 14, 2020

News Conference News TCT 2020

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Michael O'Riordan

October 14, 2020

Presentation TCT 2019

Potential of NaF PET Imaging for Vulnerable Plaque and Patient Identification

Presenter: Bon-Kwon Koo

September 27, 2019

Presentation TCT 2019

Integration of Non-Invasive and Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Presenter: Ryan Madder

September 27, 2019

Presentation TCT 2019

Non-Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Presenter: James Min

September 27, 2019

Presentation TCT 2019

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

Presenter: Farouc Jaffer

September 27, 2019

Presentation TCT 2019

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Presenter: Peter Stone

September 27, 2019

Advertisement

TCT 1012: Pre-Emptive PCI in Vulnerable Coronary Plaques Reduces Biomechanical and Anatomic High-Risk Features: The PROSPECT ABSORB Trial

TCT 1017: First-in-Human Intracoronary Structural-Molecular Imaging for Multi-Targeted Characterization of High-Risk Plaques in Patients With Coronary Artery Disease

Con

Pro

TCT 1010: Enhanced Clinical Benefit of Preventive PCI of Vulnerable Coronary Plaques in Patients With Concomitant Non-Target Vessel PCI: A Prespecified Subgroup Analysis of the PREVENT Trial

Lipid Burden and Efficacy of Preventive PCI in Vulnerable Atherosclerotic Coronary Plaques: Post-hoc Analysis of PREVENT Trial

Are Progression/Regression Studies “Good Enough” Surrogates for Rcts With Clinical Endpoints?

Vulnerable Plaque Stabilization: Lessons From Serial Intravascular Imaging Studies

Vulnerable Plaque Detection: The Time Has Passed

Vulnerable Plaque Detection: We Must Keep Looking

What Is a Vulnerable Plaque? Lessons From Intravascular Imaging

What Is a Vulnerable Plaque? Lessons From Histopathology

Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques: The DEBuT-LRP Study

The PROSPECT ABSORB Trial: Randomized Evaluation of Vulnerable Plaque Treatment with Percutaneous Coronary Intervention

Prophylactic PCI of Vulnerable Plaques? PROSPECT II/ABSORB

Potential of NaF PET Imaging for Vulnerable Plaque and Patient Identification

Integration of Non-Invasive and Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Non-Invasive Imaging for the Detection of Vulnerable Plaques and Patients

Utility of OCT-NIRF Molecular Imaging for Vulnerable Plaque Identification

PSS vs. ESS vs. WSS: What’s the Difference — and Do They Matter?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content